Compared to three years ago, feels like the regulatory ecosystem is noticeably telegraphing more favourable sentiments across a number of domains important to Mesoblast. More please.
Cell Therapy News/Articles, page-16694
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.003(0.23%) |
Mkt cap ! $1.270B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $5.381M | 4.812M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 65917 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 60847 | 13 |
View Market Depth
| Last trade - 14.09pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |